Alaska Air Group Inc
Change company Symbol lookup
Select an option...
ALK Alaska Air Group Inc
HSBC HSBC Holdings PLC
HFWA Heritage Financial Corp
SUI Sun Communities Inc
SON Sonoco Products Co
KALU Kaiser Aluminum Corp
RS Reliance Steel & Aluminum Co
HCSG Healthcare Services Group Inc
NURO NeuroMetrix Inc
HRI Herc Holdings Inc
Go

Industrials : Airlines | Mid Cap Value
Company profile

Alaska Air Group, Inc. is the holding company of Alaska Airlines (Alaska), Virgin America Inc., Horizon Air (Horizon) and other business units. The Company operates through three segments: Mainline, Regional and Horizon. Its Mainline segment includes Alaska's and Virgin America's scheduled air transportation for passengers and cargo throughout the United States, and in parts of Canada, Mexico, Costa Rica and Cuba. Its Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the United States under capacity purchased arrangements (CPAs). Its Horizon segment includes the capacity sold to Alaska under CPA. Alaska and Virgin America operate fleets of narrowbody passenger jets. As of December 31, 2016, it maintained two frequent flyer plans: the Alaska Airlines Mileage Plan and the Virgin America Elevate.

Closing Price
$40.59
Day's Change
0.90 (2.27%)
Bid
--
Ask
--
B/A Size
--
Day's High
41.32
Day's Low
38.90
Volume
(Above Average)
Volume:
2,675,840

10-day average volume:
2,278,915
2,675,840

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm

2:31 pm ET September 16, 2020 (Globe Newswire) Print

Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Rosetta Stone Inc. (NYSE: RST), Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), Jernigan Capital, Inc. (NYSE: JCAP), and Varian Medical Systems, Inc. (NYSE: VAR). Additional information about each potential action can be found at the link provided.

Rosetta Stone Inc. (NYSE: RST)

Buyer: Cambium Learning Group

On August 31, 2020, Rosetta Stone announced that it had signed an agreement to be acquired by Cambium for approximately $792 million. Pursuant to the merger agreement, Rosetta Stone stockholders will receive $30 in cash for each share of Rosetta Stone common stock owned. The deal is scheduled to close in the fourth quarter of 2020.

Bragar Eagel & Squire is concerned that Rosetta Stone's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Rosetta Stone's stockholders.

To learn more about the Rosetta Stone investigation go to: https://bespc.com/rst/.

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)

Buyer: Johnson & Johnson

On August 19, 2020, Momenta announced that it had signed an agreement to be acquired by JNJ for approximately $6.5 billion. Pursuant to the merger agreement, Momenta's stockholders will receive $52.50 in cash for each share of Momenta common stock owned. The deal is scheduled to close in the second half of 2020.

Bragar Eagel & Squire is concerned that Momenta's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Momenta's stockholders.

To learn more about the Momenta investigation go to: https://bespc.com/mnta/.

Jernigan Capital, Inc. (NYSE: JCAP)

Buyer: NexPoint Advisors, L.P.

On August 3, 2020, Jernigan announced that it had signed an agreement to be acquired by NexPoint Advisors for approximately $900 million. Pursuant to the merger agreement, Jernigan's stockholders will receive $17.30 in cash for each share of Jernigan common stock owned. The deal is scheduled to close in the fourth quarter of 2020.

Bragar Eagel & Squire is concerned that Jernigan's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Indeed, Jernigan shares have recently traded well above the merger consideration of $17.30 per share. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Jernigan's stockholders.

To learn more about the Jernigan investigation go to: https://bespc.com/jcap/.

Varian Medical Systems, Inc. (NYSE: VAR)

Buyer: Siemens Healthineers AG

On August 2, 2020, Varian announced that it had signed an agreement to be acquired by Siemens Healthineers for approximately $16.4 billion. Pursuant to the merger agreement, Varian's stockholders will receive $177.50 in cash for each share of Varian common stock owned. The deal is scheduled to close in the first half of 2021.

Bragar Eagel & Squire is concerned that Varian's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Varian's stockholders.

To learn more about the Varian investigation go to: https://bespc.com/var/.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.

Melissa Fortunato, Esq.

Alexandra Raymond, Esq.

investigations@bespc.com

www.bespc.com

https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.